1Young PW, Buckle DR, Cantello BC, et al. Identification of high- affinity binding sites for the insulin sensitizer rosiglitazone ( BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferators - activated receptor gamma[J]. J Pharmacol Exp Ther, 1998, 284 (2) : 751.
3OVALLE F, BELL D S. Effect of rosiglitazone versus insulin on the pancreatic beta - cell function of subjects with type 2 diabetes[J]. Diabetes Care, 2004, 27 (11): 2585-2589.
1UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J]. Lancet, 1998, 352(9131): 837.
2Young PW, Buckle DR, Cantello BC, et al. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma[J]. J Pharmacol Exp Ther, 1998, 284(2): 751.
4Gomez-Perez FJ, Fanghanel-Salmon G, Antonio-Barbosa J, et al. Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes[J]. Diabetes Metab Res Rev, 2002, 18(2):127.
5Lawrence IG. Rosiglitazone monotherapy and type 2 diabetes[J]. Diabet Med, 2001, 18(Suppl 4): 6.
6Bretzel RG, Voigt K, Schatz H. The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 1998, 106(5): 369.
7Mayerson AB, Hundal RS, Dufour S, et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes[J]. Diabetes, 2002, 51(3):797.
7Wild S, Roglic G, Green A, et al. Global prevalence of diabetes : estimates for the year 2000 and projections for 2030 [J]. Diabetes Care,2004,27(5) :1 047.
8Pitiporn S, Cyrus D, Sunil A. Cardiovascular effects of thiazoline diones [ J ]. Endocrinology, 2002,12 (2) : 126.
9张象麟.药物临床信息参考2008[M].重庆:重庆出版社.2008,1-36.
10Wild S,Roglic G,Green A,et al.Global prevalence of diabetes:es-timates for the year 2000 and projections for 2030[J].Diabeta Care,2004,27(5):1 047.
